Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-04-24
1999-11-09
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 552528, 552614, 552616, 552632, A61K 3156
Patent
active
059815175
ABSTRACT:
The invention provides new androstene derivatives having anti-inflammatory activity, pharmaceutical compositions containing them, and methods of administering them to warm-blooded animals in the treatment of inflammation. The active compounds are alkyl 17.alpha.-dichloroacetoxy-11.beta.-hydroxyandrosta-1,4-dien-3-one-17.beta. -carboxylates and related androstenes.
REFERENCES:
patent: 3258473 (1966-06-01), Kincl
patent: 3636010 (1972-01-01), Anner et al.
patent: 3828080 (1974-08-01), Phillipps et al.
patent: 3856828 (1974-12-01), Phillipps et al.
patent: 4093721 (1978-06-01), Phillipps et al.
patent: 4188385 (1980-02-01), Edwards
patent: 4198403 (1980-04-01), Alvarez
patent: 4263289 (1981-04-01), Edwards
patent: 4285937 (1981-08-01), Kalvoda
patent: 4335121 (1982-06-01), Phillipps et al.
patent: 4607028 (1986-08-01), Schmidlin
patent: 4650610 (1987-03-01), Phillipps et al.
patent: 4710495 (1987-12-01), Bodor
patent: 4996335 (1991-02-01), Bodor
patent: 5021408 (1991-06-01), Aubard et al.
patent: 5026693 (1991-06-01), Villax et al.
patent: 5223493 (1993-06-01), Boltralik
patent: 5362721 (1994-11-01), Stache et al.
Chemical Abstracts, vol. 105, No. 17, abstract No. 153397 (abstract of JP 61 007291), 1986.
Patent Abstracts of Japan, vol. 010, No. 148, C-35 (abstract of JP 61 007291), 1986.
Database WPI, Section CH, Week 8608, Derwent Publications Ltd., AN 86-052889 (abstract of JP 61 007291), 1986.
Ueno et al, J. Med. Chem., vol. 34, No. 8, pp. 2468-2473 (1991).
Jones Dwayne C.
Soft Drugs, Inc.
LandOfFree
Androstene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androstene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androstene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456141